OrthoPediatrics Corporation (KIDS)

ORTHOPEDIATRICS CORPORATION INVESTOR ALERT

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In OrthoPediatrics Corporation To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential violations of the federal securities laws against OrthoPediatrics Corporation (“OrthoPediatrics or the “Company”) (NASDAQ:KIDS).

If you suffered losses exceeding $50,000 investing in OrthoPediatrics Corporation securities  and would like to discuss your legal rights, please call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) or fill out the phone below. 

There is no cost or obligation to you.

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.

On December 2, 2020, Culper Research (“Culper”) published a that described OrthoPediatrics Corporation as having “engaged in a channel stuffing scheme that has systematically and significantly overstated revenues.” The Culper report alleged that “the Company has abused its ability to book revenues upon shipment by selling and shipping excess product directly to its distributors, many of whom are exclusive to the Company” and described it as "concerning that many of the Company's ‘exclusive distributors’ are simply former OrthoPediatrics employees who have formed their own distributorships, often while still employed at the Company.” On this news, OrthoPediatrics Corporation’s stock price fell $4.12 per share, or 9.13%, to close at $41.02 per share on December 2, 2020.